中集車輛(01839.HK)與山東汽車達成戰略合作
中集車輛(01839.HK)(301039.SZ)與山東汽車在山東萊陽正式簽訂戰略合作協定,雙方通過合作在物流運輸廂式化趨勢下,共同取得市場突破。
根據此次戰略合作框架協定,雙方將在新產品開發、全球化領域展開深度合作。中集車輛將積極開展產學研活動,提高自身研發能力和產品技術水準,同時持續優化成本。山東汽車將根據中集車輛產品資源和產品成本情況,在產品上對中集車輛原廠箱進行資源規劃,在新產品上亦將拓展開發中集車輛產品。
另一方面,雙方通過優勢互補積極擁抱全球化,山東汽車支持中集車輛的全球化生產佈局,中集車輛亦將利用自身海外資源為山東汽車全球化提供支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.